RMD 241.61 (+0.02%)
US7611521078• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. RMD

ResMed (RMD) Competitor Comparison

We are evaluating the key criteria listed to compare ResMed (RMD) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

4 / 44

Gross Profits

6 / 40

Total Revenue

6 / 43

EBITDA

6 / 44

Free Cashflow

6 / 44

Quick Ratio

36 / 44

Earnings per Share

1 / 44

Dividend yield

8 / 13

Total Cash

17 / 44

Performance 3 years

16 / 44

Performance 5 years

8 / 44

Performance 10 years

10 / 44

Linearity 3 years

10 / 44

Linearity 5 years

27 / 44

Linearity 10 years

39 / 44

Total Rank

2 / 44

Dividend Rank

1 / 44

Valuation Rank

13 / 44

Piotroski Rank

21 / 44

Muliplier Rank

24 / 44

Performance 3 years - RMD ranking 16 / 44

These are the competitors of ResMed in the industry Medical Instruments & Supplies ranked by performance 3 years
1. Glaukos GKOS
171.86
2. Pro-Dex PDEX
106.08
3. LeMaitre Vascular LMAT
85.73
4. Haemonetics HAE
51.43
5. Merit Medical Systems MMSI
48.78
6. Intuitive Surgical ISRG
48.41
7. Hologic HOLX
6.68
8. Bausch & Lomb BLCO
5.78
9. Alcon ALC
2.57
10. electroCore ECOR
-0.87
11. Ansell PD1.F
-3.82
12. Steris STE
-5
13. Cooper Companies COO
-5.21
14. Becton, Dickinson BDX
-7.99
15. KORU Medical Systems KRMD
-13.48
16. ResMed RMD
-13.62
17. Pulse Biosciences PLSE
-20.71
18. iRhythm Technologies IRTC
-22.11
19. West Pharmaceutical Services WST
-24.76
20. NexGel NXGL
-27.73
21. ICU Medical ICUI
-29.59
22. Atrion ATRI
-34.64
23. Utah Medical Products UTMD
-39.55
24. Teleflex TFX
-43.89
25. Repligen RGEN
-45.21
26. Masimo MASI
-46.78
27. Envista Holdings NVST
-53.52
28. BioLife Solutions BLFS
-53.9
29. AtriCure ATRC
-54.63
30. Baxter BAX
-59.84
31. OraSure Technologies OSUR
-60.18
32. Warby Parker WRBY
-64.41
33. Dentsply Sirona XRAY
-67.64
34. Harvard Bioscience HBIO
-71.73
35. Staar Surgical STAA
-75.9
36. Akoya Biosciences AKYA
-76.64
37. AngioDynamics ANGO
-77.04
38. Nephros NEPH
-78.65
39. Ekso Bionics Holdings EKSO
-79.88
40. NovoCure NVCR
-85.73
41. Microbot Medical MBOT
-87.69
42. Femasys FEMY
-92.74
43. NeuroMetrix NURO
-94.08
44. Predictive Oncology POAI
-95.59
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.